Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis

Objectives Our objective was to examine coronary endothelial and myocardial programming in patients with severe COVID-19 utilizing digital spatial transcriptomics. Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has well-established links to thrombotic and cardiovascular events. Endothelial cell infection was initially proposed to initiate vascular events; however, this paradigm has sparked growing controversy. The significance of myocardial infection also remains unclear. Methods Autopsy-derived cardiac tissue from control (n = 4) and COVID-19 (n = 8) patients underwent spatial transcriptomic profiling to assess differential expression patterns in myocardial and coronary vascular tissue. Our approach enabled transcriptional profiling in situ with preserved anatomy and unaltered local SARS-CoV-2 expression. In so doing, we examined the paracrine effect of SARS-CoV-2 infection in cardiac tissue. Results We observed heterogeneous myocardial infection that tended to colocalize with CD31 positive cells within coronary capillaries. Despite these differences, COVID-19 patients displayed a uniform and unique myocardial transcriptional profile independent of local viral burden. Segmentation of tissues directly infected with SARS-CoV-2 showed unique, pro-inflammatory expression profiles including upregulated mediators of viral antigen presentation and immune regulation. Infected cell types appeared to primarily be capillary endothelial cells as differentially expressed genes included endothelial cell markers. However, there was limited differential expression within the endothelium of larger coronary vessels. Conclusions Our results highlight altered myocardial programming during severe COVID-19 that may in part be associated with capillary endothelial cells. However, similar patterns were not observed in larger vessels, diminishing endotheliitis and endothelial activation as key drivers of cardiovascular events during COVID-19. Condensed Abstract SARS-CoV-2 is linked to thrombotic and cardiovascular events; however, the mechanism remains uncertain. Our objective was to examine coronary endothelial and myocardial programming in patients with severe COVID-19 utilizing digital spatial transcriptomics. Autopsy-derived coronary arterial and cardiac tissues from control and COVID-19 patients underwent spatial transcriptomic profiling. Our approach enabled transcriptional profiling in situ with preserved anatomy and unaltered local SARS-CoV-2 expression. We observed unique, pro-inflammatory expression profiles among all COVID-19 patients. While heterogeneous viral expression was noted within the tissue, SARS-CoV-2 tended to colocalize with CD31 positive cells within coronary capillaries and was associated with unique expression profiles. Similar patterns were not observed in larger coronary vessels. Our results highlight altered myocardial programming during severe COVID-19 that may in part be associated with capillary endothelial cells. Such results diminish coronary arterial endotheliitis and endothelial activation as key drivers of cardiovascular events during COVID-19 infection. LIST OF HIGHLIGHTS SARS-CoV-2 has variable expression patterns within the myocardium of COVID-19 patients SARS-CoV-2 infection induces a unique myocardial transcriptional programming independent of local viral burden SARS-CoV-2 myocarditis is predominantly associated with capillaritis, and tissues directly infected with SARS-CoV-2 have unique, pro-inflammatory expression profiles Diffuse endothelial activation of larger coronary vessels was absent, diminishing large artery endotheliitis as a significant contributor to cardiovascular events during COVID-19 infection.

[1]  T. Assimes,et al.  A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility , 2022, NPJ genomic medicine.

[2]  Q. Su,et al.  Interaction between Sars-CoV-2 structural proteins and host cellular receptors: From basic mechanisms to clinical perspectives , 2022, Advances in Protein Chemistry and Structural Biology.

[3]  P. Kirchhof,et al.  Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart , 2021, Cardiovascular research.

[4]  Xiaomin Wang,et al.  Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01 , 2021, EClinicalMedicine.

[5]  P. Libby,et al.  Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis , 2021, The American Journal of Pathology.

[6]  L. Dölken,et al.  SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro , 2021, Frontiers in Cellular and Infection Microbiology.

[7]  M. Mirsaeidi,et al.  COVID-19 and Cardiomyopathy: A Systematic Review , 2021, Frontiers in Cardiovascular Medicine.

[8]  T. Assimes,et al.  IL10RB as a key regulator of COVID-19 host susceptibility and severity , 2021, medRxiv.

[9]  H. Keyvani,et al.  Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions , 2021, BioMed research international.

[10]  Timothy L. Tickle,et al.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.

[11]  B. Lie,et al.  The influence of HLA genotype on the severity of COVID‐19 infection , 2021, HLA.

[12]  A. Gaggar,et al.  Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures , 2021, Cell Reports Medicine.

[13]  M. Diamond,et al.  SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2021, JACC: Basic to Translational Science.

[14]  Nicky Phillips,et al.  The coronavirus is here to stay — here’s what that means , 2021, Nature.

[15]  J. Haas,et al.  Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells , 2021, Circulation.

[16]  H. Moch,et al.  SARS-CoV-2 leads to a small vessel endotheliitis in the heart , 2021, EBioMedicine.

[17]  Dingyu Zhang,et al.  The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019 , 2020, Critical Care.

[18]  M. Diamond,et al.  SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2020, bioRxiv.

[19]  L. Papazian,et al.  Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 , 2020, The Journal of infectious diseases.

[20]  D. Lewis,et al.  COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives , 2020, Nature Reviews Cardiology.

[21]  Sharon J Peacock,et al.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[22]  Karlheinz Peter,et al.  The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications , 2020, Circulation research.

[23]  P. Carmeliet,et al.  COVID-19: the vasculature unleashed , 2020, Nature Reviews Immunology.

[24]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[25]  Hongliang Li,et al.  The Science Underlying COVID-19: Implications for the Cardiovascular System. , 2020, Circulation.

[26]  J. Manson,et al.  Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases , 2013, Genome Medicine.

[27]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[28]  B. Berk,et al.  Angiotensin II and the Endothelium: Diverse Signals and Effects , 2005, Hypertension.

[29]  R. Hynes,et al.  Plasma fibronectin promotes thrombus growth and stability in injured arterioles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Robert C. Wolpert,et al.  A Review of the , 1985 .